PredictImmune: Announced as Finalist in the Cambridge Independent Science & Technology Awards
Cambridge, UK, 14th September 2018: PredictImmune is pleased to be selected as one of the finalists, in the “start up of the year” category of the Cambridge Independent’s Science and Technology awards.
The finalists for the awards, which are now in their second year, were selected from a huge number of high quality entries received across 12 categories. The judging panel is chaired by editor Paul Brackley, and includes Cambridge entrepreneur Charles Cotton, AstraZeneca’s Sabine Jaccaud, Barbara Fleck from patent attorneys Appleyard Lees, Kristen Riley from business and financial advisors Grant Thornton, and Martin Smith from Woodfines Solicitors.
Winners will be announced at a ceremony on November 1, following a judging session on Friday September 7.